221 related articles for article (PubMed ID: 18212301)
1. New drugs for the treatment of diabetes mellitus: part I: Thiazolidinediones and their evolving cardiovascular implications.
McGuire DK; Inzucchi SE
Circulation; 2008 Jan; 117(3):440-9. PubMed ID: 18212301
[No Abstract] [Full Text] [Related]
2. Protecting the heart while controlling blood sugar. New guidelines help define and refine the use of two diabetes drugs that could be a boon for people who also have heart disease.
Harv Heart Lett; 2004 Mar; 14(7):1. PubMed ID: 15044139
[No Abstract] [Full Text] [Related]
3. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
Hemmingsen B; Lund SS; Vaag A
Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642
[TBL] [Abstract][Full Text] [Related]
4. Thiazolidinediones and cardiovascular outcomes in type 2 diabetes.
Singh S; Furberg CD
Heart; 2009 Jan; 95(1):1-3. PubMed ID: 18753156
[No Abstract] [Full Text] [Related]
5. [Prophylactic and therapeutic application of thiamine (vitamin B1)--a new point of view].
Małecka SA; Poprawski K; Bilski B
Wiad Lek; 2006; 59(5-6):383-7. PubMed ID: 17017487
[TBL] [Abstract][Full Text] [Related]
6. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.
Skyler JS; Bergenstal R; Bonow RO; Buse J; Deedwania P; Gale EA; Howard BV; Kirkman MS; Kosiborod M; Reaven P; Sherwin RS; ; ;
J Am Coll Cardiol; 2009 Jan; 53(3):298-304. PubMed ID: 19147051
[No Abstract] [Full Text] [Related]
7. [Positioning of PROactive and its clinical application in Japan--a new direction in diabetes care discussed by diabetology and circulatory disease specialists: discussion].
Kawamori R; Kadowaki T; Daida H; Takeda N; Dormandy J
Nihon Rinsho; 2006 Mar; 64(3):581-7. PubMed ID: 16732624
[No Abstract] [Full Text] [Related]
8. The question of whether diabetes and its cardiovascular risks can be prevented: a realistic DREAM?
Hedner T; Narkiewicz K; Oparil S; Kjeldsen SE
Blood Press; 2006; 15(5):260-2. PubMed ID: 17380842
[No Abstract] [Full Text] [Related]
9. The clinical implications of the CHICAGO study for the management of cardiovascular risk in patients with type 2 diabetes mellitus.
Polonsky T; Mazzone T; Davidson M
Trends Cardiovasc Med; 2009 Apr; 19(3):94-9. PubMed ID: 19679266
[TBL] [Abstract][Full Text] [Related]
10. A lesson in moderation: applying pharmacodynamics to clarify the relationship between thiazolidinediones and adverse vascular outcomes in type 2 diabetes.
Lehmann DF; Lohray BB
J Clin Pharmacol; 2008 Aug; 48(8):999-1002. PubMed ID: 18650500
[No Abstract] [Full Text] [Related]
11. Glitazones in type 2 diabetes: an update.
Drug Ther Bull; 2008 Apr; 46(4):25-9. PubMed ID: 18403615
[TBL] [Abstract][Full Text] [Related]
12. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
Standl E; Schnell O
Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
[No Abstract] [Full Text] [Related]
13. Glycosaminoglycan therapy for long-term diabetic complications?
Gambaro G; Skrha J; Ceriello A
Diabetologia; 1998 Aug; 41(8):975-9. PubMed ID: 9726602
[No Abstract] [Full Text] [Related]
14. Statin power.
Diabetes Forecast; 2008 Apr; 61(4):28. PubMed ID: 18478640
[No Abstract] [Full Text] [Related]
15. [Anti-diabetic therapy and cardiovascular risk].
Mannucci E
G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):3S. PubMed ID: 25623544
[No Abstract] [Full Text] [Related]
16. Frequency of undiagnosed and untreated diabetes mellitus in patients with acute coronary syndromes.
Conaway DG; O'Keefe JH
Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):503-7. PubMed ID: 16918268
[TBL] [Abstract][Full Text] [Related]
17. Lipid lowering in diabetes mellitus.
Betteridge DJ
Curr Opin Lipidol; 2008 Dec; 19(6):579-84. PubMed ID: 18957880
[TBL] [Abstract][Full Text] [Related]
18. An overview of what diabetes can do to your body (and what you can do to prevent it).
Gebel E
Diabetes Forecast; 2008 Dec; 61(12):45-6. PubMed ID: 19145747
[No Abstract] [Full Text] [Related]
19. Glycaemic control and vascular complications in type 2 diabetes: new observations and clinical significance.
Lebovitz HE
J Indian Med Assoc; 2008 Nov; 106(11):724-6. PubMed ID: 19368098
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic effects of thiazolidinediones.
Rizos CV; Liberopoulos EN; Mikhailidis DP; Elisaf MS
Expert Opin Pharmacother; 2008 May; 9(7):1087-108. PubMed ID: 18422468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
